PuraPharm (HKSE:01498) Days Payable : 247.55 (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is PuraPharm Days Payable?

PuraPharm's average Accounts Payable for the six months ended in Dec. 2023 was HK$145.2 Mil. PuraPharm's Cost of Goods Sold for the six months ended in Dec. 2023 was HK$107.1 Mil. Hence, PuraPharm's Days Payable for the six months ended in Dec. 2023 was 247.55.

The historical rank and industry rank for PuraPharm's Days Payable or its related term are showing as below:

HKSE:01498' s Days Payable Range Over the Past 10 Years
Min: 89.68 Med: 184.65 Max: 274.28
Current: 273.99

During the past 10 years, PuraPharm's highest Days Payable was 274.28. The lowest was 89.68. And the median was 184.65.

HKSE:01498's Days Payable is ranked better than
87.82% of 977 companies
in the Drug Manufacturers industry
Industry Median: 87.01 vs HKSE:01498: 273.99

PuraPharm's Days Payable declined from Dec. 2022 (251.47) to Dec. 2023 (247.55). It may suggest that PuraPharm accelerated paying its suppliers.

PuraPharm Days Payable Historical Data

The historical data trend for PuraPharm's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PuraPharm Days Payable Chart

PuraPharm Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

195.49

266.30

231.77

274.28

272.74

PuraPharm Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial															202.22	329.60	251.47	309.46	247.55

Competitive Comparison of PuraPharm's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, PuraPharm's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PuraPharm's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PuraPharm's Days Payable distribution charts can be found below:

* The bar in red indicates where PuraPharm's Days Payable falls into.

PuraPharm Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

PuraPharm's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (137.911	+	146.379)	/	2 )	/	190.23	*	365
=	142.145					/	190.23	*	365
=	272.74

PuraPharm's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (144.095	+	146.379)	/	2 )	/	107.074	*	365 / 2
=	145.237					/	107.074	*	365 / 2
=	247.55

PuraPharm Days Payable Related Terms

Thank you for viewing the detailed overview of PuraPharm's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

PuraPharm (HKSE:01498) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PuraPharm Corporation Ltd (HKSE:01498) » Definitions » Days Payable

Traded in Other Exchanges

N/A

Address

Wireless Centre, Phase One, Unit 201-207, 2nd Floor, Hong Kong Science Park, Tai Po, New Territories, Hong Kong, HKG

Website

https://www.purapharm.com

PuraPharm Corporation Ltd is a Hong Kong-based Chinese medicine Company. It is engaged in the research and development, production, marketing and sale of concentrated Chinese medicine granules (CCMG) products marketed under the brand Nong's. In addition, the organization is engaged in rendering Chinese medical diagnostic services. The operating segments of the group are China CCMG, Hong Kong CCMG, Chinese healthcare products, Plantation and Clinics. It generates maximum revenue from the China CCMG segment mainly engages in the production and sale of CCMG products in China. The group derives revenue from the customers located in Hong Kong, Mainland China and Other countries.

PuraPharm (HKSE:01498) Headlines

No Headlines